Assistant Professor of Neurosurgery, Orthopedic Surgery, & Oncology
Daniel Sciubba obtained his undergraduate degree from Duke University and his medical degree from Columbia University College of Physicians and Surgeons. As a medical student, Daniel was recognized with a prestigious award from the Howard Hughes Medical Institute for basic science research in neurophysiology. Upon graduation, he was also recognized with Alpha Omega Alpha honors and was named Valedictorian of his graduating class. Dr. Sciubba completed his residency training in neurological surgery at the Johns Hopkins Hospital in 2009.
Since joining the Department of Neurosurgery in 2002, Dr. Sciubba’s contributions in clinical outcomes and hospital safety research have earned him multi-year research funding from the National Institutes of Health (NIH), the Congress of Neurological Surgeons (CNS), and the American Association of Neurological Surgeons (AANS). Most recently, Dr. Sciubba was awarded the North American Spine Society (NASS) Research Grant for his research on novel treatment for spinal metastases using animal models of spine tumors. Dr. Sciubba’s research efforts have directly resulted in the standardized use of antibiotic-impregnated shunt catheters for children with hydrocephalus at the Johns Hopkins Hospital where he was recently recognized with the Johns Hopkins Hospital safety award for significant published contributions to improve the safety of neurosurgical care.
Currently, Dr. Sciubba serves as a Co-Investigator of the Spinal Column Biomechanics and Surgical Outcomes Laboratory, resident-liaison to the Spinal Oncology Study Group, and officer on the AANS/CNS Young Neurosurgeons Committee, from which he also serves as a resident-liaison to the AANS/CNS Section of Disorders of Spine and Peripheral Nerves. He recently completed an intramural clinical spine fellowship under the direction of his mentor, Dr. Ziya Gokaslan.
Dr. Sciubba’s current research interests focus on developing new treatment options for the management of spine tumors, creating and refining new animal models of spine tumors, biomechanically evaluating current and novel spine instrumentation constructs, and assessing the efficacy of surgical and medical therapeutics for spinal pathology through prospective and retrospective outcomes studies.